Dolby Laboratories Inc
For the period ended Sep 27, 2024. Filed Nov 19, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Nov 19, 2024
DLB$64.67-0.2%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Comprehensive Income
| Fiscal Year Ended | |||
|---|---|---|---|
| September 27,2024 | September 29,2023 | September 30,2022 | |
| Net income including noncontrolling interest | $264,316 | $201,644 | $183,898 |
| Other comprehensive income: | |||
| Currency translation adjustments gains/(losses), net of tax benefit/(expense) of $65, $73, and ($245) | 15,098 | 7,574 | (31,586) |
| Unrealized gains/(losses) on investments, net of tax benefit of ($21), $54, and $50 | 2,775 | 3,128 | (6,206) |
| Unrealized gains/(losses) on cash flow hedges, net of tax benefit/(expense) of ($344), $85, and $324 | 197 | 4,286 | (4,361) |
| Total other comprehensive income/(loss), net of tax | 18,070 | 14,988 | (42,153) |
| Total comprehensive income | 282,386 | 216,632 | 141,745 |
| Less: comprehensive (income)/loss attributable to noncontrolling interest | (2,764) | (1,319) | 731 |
| Comprehensive income attributable to Dolby Laboratories, Inc. | $279,622 | $215,313 | $142,476 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.